In an abrupt reversal, the US Department of Health and Human Services said Thursday that it no longer plans to cut funding ...

We explore the current guidance for osteoporosis screening in men, as well as barriers to access for both clinicians and ...

Denosumab plus romosozumab vs denosumab only was associated with improved bone mineral density among patients with severe ...

Health care professionals should assess baseline bone mineral density in patients with osteoporosis before determining ...

Romosozumab vs bisphosphonate use was not linked to increased CVD risks among patients with osteoporosis, challenging past concerns over its cardiovascular safety.

In postmenopausal patients with ulcerative colitis (UC) or Crohn’s disease (CD), approximately one-third had osteoporosis while approximately 40% had osteopenia. 2. In men aged over 50 years with UC ...

In this column, we will aim to raise awareness about osteoporosis, highlighting the importance of early screening and timely ...

today presented positive preclinical data demonstrating the satisfactory safety profile of its hydrocelin injectable ...